Form 4 holding
Chief Scientific Officer
Aclaris Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 265,662
- Estimated value
- $528,667
- Report date
- 01 Mar 2025
- Price
- $1.99
- Ownership
- Direct
Joseph Monahan - Chief Scientific Officer at Aclaris Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Scientific Officer
- Issuer ticker
- ACRS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Joseph Monahan since 14 Oct 2025
Reported holdings for Joseph Monahan in Aclaris Therapeutics, Inc.
Form 4 holding
Chief Scientific Officer
Aclaris Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 10,925
- Estimated value
- $21,741
- Report date
- 01 Mar 2025
- Price
- $1.99
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Scientific Officer
Aclaris Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 193
- Estimated value
- $384
- Report date
- 01 Mar 2025
- Price
- $1.99
- Ownership
- By Spouse
Form 4 holding
Chief Scientific Officer
Aclaris Therapeutics, Inc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 293,500
- Estimated value
- Report date
- 03 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Joseph Monahan in Aclaris Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.